Registration is now open for the 2022 ABTA National Conference, the nation’s largest advocacy-led educational meeting designed for brain tumor patients, survivors, and caregivers — online Friday, Sept. 9 and Saturday, Sept. 10, 2022.
The free, two-day conference gathers thousands of patients, caregivers, and survivors to learn the latest in brain tumor research, treatment and care from leading experts.
This year’s program features new ways for attendees to connect with one another, interact with doctors, and hear directly from patients.
Cutting-Edge Brain Tumor Education
Join us to hear about the latest research initiatives, advances in diagnosis and treatment, and developments in brain tumor management and care.
Sessions cover topics relating to all major brain tumor types and stages of diagnosis, including:
- Innovations in Awake Brain Mapping in Brain Surgery
- Advances in Radiotherapy Treatments & Technology
- Improving Quality of Life After a Diagnosis
- Changes to Brain Tumor Classifications & What It Means for Patients
- Emerging Research & Clinical Trials
- Inside Look at a Brain Tumor Board
- And More!
Participate in live Q&A with speakers and hear from patients who will speak to the specific treatment or diagnosis.
View the full program and speaker lineup here.
New Opportunities to Connect
This year’s conference will offer virtual roundtables and speed networking for small groups of attendees, including healthcare professionals, to interact and share information. 
Breakout sessions will give attendees a personalized discussion by allowing them to choose specific sessions of interest and move around to different breakout rooms.
Take part in conversations on forward-looking research, view research posters from leading brain tumor scientists, and meet with others who have or are experiencing a similar journey to yours!
Led by National Experts
The 2022 National Conference is co-chaired by Nancy Ann Oberheim Bush, MD, PhD, of the University of California, San Francisco, and Vinai Gondi, MD, of Northwestern Medicine.
Nancy is an academic Neuro-Oncologist at UCSF where she serves as Director of Clinical Services. She has a passion for excellent patient care and research interests in the development of novel agents to treat both glioma and meningioma.
Vinai is the Director of Research & Education at the Northwestern Medicine Proton Center and Co-Director of the Brain Tumor Center at Northwestern Medicine Cancer Center Warrenville. He specializes in the management of brain, skull base and spine tumors, with a research focus on the development and clinical trial testing of novel radiotherapy techniques.
This year’s co-chairs have brought together national experts from leading medical institutions, including Massachusetts General Hospital, Miami Cancer Institute, Mayo Clinic, MD Anderson Cancer Center, and more for dynamic sessions and panel discussions.
Jessie Schlacks
Jessie is Managing Editor of the bi-monthly e-newsletter MindMatters. Submit story ideas or questions to jschlacks@abta.org.
